Clorox Analysts Boost Their Forecasts Following Upbeat Earnings
Clorox Company CLX reported better-than-expected second-quarter financial results Monday after the bell.
Clorox Beats Q2 Earnings & Sales Estimates, Updates FY25 Outlook
CLX's Q2 results reflect strong core fundamentals, market share gains and gross margin expansion amid cyberattack recovery and divestitures.
The Clorox Company (CLX) Q2 2025 Earnings Conference Call Transcript
The Clorox Company (NYSE:CLX ) Q2 2025 Earnings Conference Call February 3, 2025 5:00 PM ET Company Participants Lisah Burhan - Vice President, Investor Relations Linda Rendle - Chair and CEO Kevin Jacobsen - Chief Financial Officer Luc Bellet - Treasurer and Incoming CFO Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Filippo Falorni - Citi Anna Lizzul - Bank of America Kaumil Gajrawala - Jefferies Bonnie Herzog - Goldman Sachs Chris Carey - Wells Fargo Olivia Tong - Raymond James Andrea Teixeira - JP Morgan Robert Moskow - TD Cowen Kevin Grundy - BNP Paribas Linda Bolton Weiser - D.A. Davidson Javier Escalante - Evercore ISI Steve Powers - Deutsche Bank Lauren Lieberman - Barclays Operator Good day, ladies and gentlemen, and welcome to The Clorox Company Second Quarter Fiscal Year 2025 Earnings Release Conference Call.
Clorox (CLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox (CLX) Surpasses Q2 Earnings and Revenue Estimates
Clorox (CLX) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $2.16 per share a year ago.
Markets React to Softening Trade Tariff Policy
An almost immediate retraction of a 25% tariff on imported goods from Mexico prodded this relief trade.
Steven Cress' Top 10 Dividend Stocks For 2025
Steven Cress talks to Kim Khan about his top dividend stocks for the year. Diversification and strong fundamentals are key strategies for investors.
Clorox Is Overpriced Versus Other Consumer Staples Stocks (Rating Downgrade)
The consumer staples sector has struggled due to rising costs, e-commerce, and consumer resistance to price hikes, lagging significantly behind the S&P 500. The Clorox Company might seem like an opportunity, but its shares are expensive compared to other staples names. Clorox faces the same long-term issues as the sector, such as margin compression and competition from store brands.
Clorox Gears Up for Upcoming Q2 Earnings: Here's What You Should Know
CLX is poised for growth as its IGNITE Strategy drives innovation, efficiency and international expansion amid a challenging market.
Clorox Trading Above 200-Day SMA: Is the Stock Worth Buying?
CLX looks poised for growth through recent recovery, improved distribution channels and focus on innovation and expansion despite facing some cost challenges.
Clorox (CLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Clorox (CLX) Could Beat Earnings Estimates Again
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
